C Tzourio

Author PubWeight™ 62.87‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet 2013 9.46
2 Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 1994 6.05
3 Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. J Neurol Neurosurg Psychiatry 1997 3.14
4 Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort. Neurology 2001 2.18
5 Dietary patterns and risk of dementia: the Three-City cohort study. Neurology 2007 2.09
6 The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med 1992 1.80
7 Association of plasma amyloid beta with risk of dementia: the prospective Three-City Study. Neurology 2009 1.70
8 Early epidural blood patch in spontaneous intracranial hypotension. Neurology 2004 1.59
9 Risk profiles for mild cognitive impairment and progression to dementia are gender specific. J Neurol Neurosurg Psychiatry 2008 1.56
10 Long-term prognosis in cerebral venous thrombosis. Follow-up of 77 patients. Stroke 1996 1.54
11 Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. Mol Psychiatry 2009 1.51
12 Self-rated health and risk of incident dementia: a community-based elderly cohort, the 3C study. Neurology 2011 1.50
13 APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study. Neurology 2005 1.50
14 Olive oil consumption, plasma oleic acid, and stroke incidence: the Three-City Study. Neurology 2011 1.48
15 Aortic plaque morphology and vascular events: a follow-up study in patients with ischemic stroke. FAPS Investigators. French Study of Aortic Plaques in Stroke. Circulation 1997 1.46
16 Influence of education on the relationship between white matter lesions and cognition. Neurology 2003 1.35
17 Familial aggregation of Parkinson's disease: a population-based case-control study in Europe. EUROPARKINSON Study Group. Neurology 1999 1.29
18 Chronic kidney disease, cognitive decline, and incident dementia: the 3C Study. Neurology 2011 1.28
19 Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3C-Dijon Study. Neurology 2012 1.28
20 Frequency and location of dilated Virchow-Robin spaces in elderly people: a population-based 3D MR imaging study. AJNR Am J Neuroradiol 2011 1.23
21 Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. Mol Psychiatry 2012 1.20
22 Neuroimaging correlates of subjective memory deficits in a community population. Neurology 2008 1.18
23 The second (main) phase of an open, randomised, multicentre study to investigate the effectiveness of an intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT2). Int J Stroke 2010 1.17
24 [Cervical artery dissection: recent data physiopathologic hypotheses]. Rev Med Interne 1999 1.12
25 Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial. Stroke 2003 1.11
26 Characteristics of hormone therapy, cognitive function, and dementia: the prospective 3C Study. Neurology 2009 1.03
27 Association of polymorphisms in the Tau and Saitohin genes with Parkinson's disease. J Neurol Neurosurg Psychiatry 2004 1.01
28 Resting heart rate, mortality and future coronary heart disease in the elderly: the 3C Study. Eur J Cardiovasc Prev Rehabil 2011 1.01
29 Influence of apolipoprotein E genotype on the risk of cognitive deterioration in moderate drinkers and smokers. Epidemiology 2000 1.01
30 Metabolic syndrome and cognitive decline in French elders: the Three-City Study. Neurology 2011 0.99
31 Mitral valve strands and the risk of ischemic stroke in elderly patients. The French Study of Aortic Plaques in Stroke (FAPS) Investigators. Stroke 1997 0.99
32 Cross-sectional association between homocysteine and motor function in the elderly. Neurology 2006 0.90
33 Lambl's excrescences and stroke. Echocardiography 2000 0.87
34 Recommendations on the risk of ischaemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine. The International Headache Society Task Force on Combined Oral Contraceptives & Hormone Replacement Therapy. Cephalalgia 2000 0.83
35 Aldosterone synthase (CYP11B2) gene polymorphism and cerebral white matter hyperintensities. Neurology 2001 0.83
36 Arterial wall properties in carotid artery dissection: an ultrasound study. Neurology 2000 0.80
37 Risk factors for progressive supranuclear palsy: a case-control study in France. J Neurol Neurosurg Psychiatry 2009 0.79
38 Parkinson's disease, smoking, and family history. EUROPARKINSON Study Group. J Neurol 2000 0.78
39 [Evaluation of aortic atherosclerosis by transesophageal echocardiography. Prognostic implications]. Arch Mal Coeur Vaiss 1997 0.78
40 A simple score to predict survival with dementia in the general population. Neuroepidemiology 2013 0.76
41 Migraine: a risk factor for ischemic stroke in young women. Stroke 1997 0.75
42 Segregation analysis in Alzheimer disease: no evidence for a major gene. Am J Hum Genet 1992 0.75
43 Teaching of neuroepidemiology in Europe: time for action. Eur J Neurol 2004 0.75
44 Verbal scales in the acute treatment of migraine: semantic categories and clinical relevance. Cephalalgia 1997 0.75
45 [The second (main) phase of an open, randomised, multicentre study to investigate the effectiveness of an INTEnsive blood pressure Reduction in Acute Cerebral hemorrhage Trial (INTERACT2): protocol and baseline characteristics of patients included in France]. Rev Neurol (Paris) 2011 0.75
46 [Towards a prevention of dementia?]. Rev Neurol (Paris) 2004 0.75
47 [Blood pressure and cognitive function]. Rev Epidemiol Sante Publique 1996 0.75
48 [Double-blind placebo-controlled European trial for systolic hypertension--and prevention of dementia]. Rev Epidemiol Sante Publique 1999 0.75